Press release
Electroceuticals: Powering the Future of Medicine | Bioelectricals Medicine Market Exhibiting a CAGR of 7.4% By 2032
Electroceuticals, or bioelectronic medicine, represents a groundbreaking frontier in healthcare. By harnessing the body's electrical signals, this innovative field is developing therapies for a wide range of conditions. The growing geriatric population serves as a pivotal driver of the global electroceuticals/bioelectric medicine market. The World Health Organization (WHO) projects a substantial increase in the global elderly population, with an estimated 1.4 billion people aged 60 years and over by 2030. Electroceuticals are medical devices that use electrical impulses to modulate neural circuits, tissues, or organs for therapeutic purposes. According to the report, the global electroceuticals/bioelectric medicine market was valued at $ 19.8 billion in 2022 and is estimated to reach $40.5 billion by 2032, exhibiting a CAGR of 7.4% from 2023 to 2032.Electroceuticals/Bioelectric Medicine Market in Short:
CAGR: 7.4%
Current Market Size: USD 40.5 Billion
Fastest Growing Region: APAC
Largest Market: North America
Projection Time: 2023-2032
Base Year: 2023
Request Downloadable Sample Copy of Report:
https://www.alliedmarketresearch.com/request-sample/A07649
How it Works?
Electroceuticals involve the use of implantable or non-invasive devices to modulate the body's electrical signals. These devices, such as pacemakers, deep brain stimulators, and vagus nerve stimulators, interact with the nervous system to treat conditions ranging from cardiac arrhythmias to chronic pain.
What are electroceuticals?
Electroceuticals are medical devices that use electrical impulses to modulate neural circuits, tissues, or organs for therapeutic purposes. They offer a non-pharmacological approach to treating various conditions such as chronic pain, neurological disorders, and psychiatric conditions.
What are the key drivers in the electroceuticals market report?
The major factor that fuels the growth of the electroceuticals market are increasing prevalence of chronic diseases, advancements in technology, and rising demand for non-invasive therapies.
Value Propositions Related to The Report:
• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
Enquire Your Every Doubt Here:
https://www.alliedmarketresearch.com/purchase-enquiry/A07649
Based on product, the cardiac pacemakers & implantable cardioverter defibrillators segment accounted for the largest share in 2022, accounting for almost two-thirds of the global electroceuticals/bioelectric medicine market revenue. This is primarily attributed to the increasing incidence of cardiovascular diseases like arrhythmias and heart failure, continuous innovations in cardiac device technology, expanding aging demographic, and heightened awareness regarding cardiovascular health and advanced treatment alternatives. These factors collectively contribute to the segment's continued dominance in revenue generation.
Based on application, the arrhythmia segment accounted for the largest share in 2022, accounting for almost two-thirds of the global electroceuticals/bioelectric medicine market revenue. This is primarily attributed to increasing prevalence of arrhythmias globally. Factors such as aging population, lifestyle changes, and advancements in arrhythmia management technologies contribute to sustained demand for diagnostic and treatment solutions in this segment.
Top Leading Key Companies -
• Medtronic
• Abbott Laboratorie
• Boston Scientific Corporation
• Cochlear Ltd.
• LivaNova PLC
• Biotronik SE & Co. KG
• ElectroCore, Inc.
• Sonova
• Nevro Corp.
• Stimwave LLC.
Market: By Region Outlook
• North America (U.S., Canada, Mexico)
• Europe (UK, Germany, France, Spain, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific)
• LAMEA (Brazil, South Africa, Turkey, Saudi Arabia, Rest of LAMEA)
Procure Complete Report @
https://www.alliedmarketresearch.com/electroceuticals-bioelectric-medicine-market/purchase-options
Important Questions Being Answered by This Market Report Are -
Q1. What is the total market value of electroceuticals market report?
Q2. What would be forecast period in the market report?
Q3. What is the market value of electroceuticals market in 2032?
Q4. Which is base year calculated in the electroceuticals market report?
Key findings of the study -
• In February 2023, LivaNova launched a new device called SenTiva DUO, an implantable pulse generator that aims to treat epilepsy in patients resistant to drug therapy. The device is specifically intended to deliver Vagus Nerve Stimulation (VNS) therapy and has a dual-pin header. The latest technology treats and offers benefits to patients who have been embedded with a dual-pin lead and IPG.
• In May 2022, Microport received approval for its platinum implantable cardioverter defibrillator (ICD) from Chinas National Medical Products Administration (NMPA). The platinum ICD was the first ICD product introduced by MicroPort Soaring CRM (Shanghai) Co., Ltd. (MSC).
𝗖𝗼𝗻𝘁𝗮𝗰𝘁:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Electroceuticals: Powering the Future of Medicine | Bioelectricals Medicine Market Exhibiting a CAGR of 7.4% By 2032 here
News-ID: 3622159 • Views: …
More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…

Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…

Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…

Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for Electroceuticals
Key Trends Influencing the Growth of the Electroceuticals Market in 2025: Transf …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Electroceuticals Market Through 2025?
In recent years, the electroceuticals market has witnessed robust growth. The market size, which stands at $22.76 billion in 2024, is set to expand to $24.19 billion in 2025, signaling a compound annual growth rate (CAGR) of 6.3%.…
Electroceuticals Market Stimulating Innovation, Improving Lives: The Rise of the …
Electroceuticals Market to reach over USD 29.06 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electroceuticals Market Size, Share & Trends Analysis Report By Product (Pacemaker, ICD, Cochlear Implant, Deep Brain, Spinal Cord, Vagus, Sacral Nerve Stimulators), Application (Ischemia, Epilepsy), Type (Implantable, Noninvasive), End User (Hospitals, Clinics, & ASCs)- Market Outlook And Industry…
UK Electroceuticals Market Size & Growth Analysis Report, 2019-2025
The UK electroceuticals market is expected to grow at a CAGR of 7.5% during the forecast period. UK has the highest number of cardiovascular diseases, coronary heart disease, stroke, heart failure, atrial fibrillation, and other heart patients in Europe. Prolonged diseases, such as arthritis, asthma, chronic obstructive pulmonary disease, diabetes, and other heart-related diseases put economic burden on the UK government, which includes cost of premature fatalities, hospital stay, and…
Electroceuticals Market Size, Share and Forecast 2019-2025
The global electroceuticals market is expected to grow at a CAGR of 7.1% during the forecast period. The global electroceuticals market is expected to grow significantly owing to various factors such as rising incidence and prevalence rate of chronic diseases, and growing investment for the development of advanced electroceuticals by major players as well as the government. Increasing prevalence of neurological disorders such as epilepsy, Parkinson’s, Paraneoplastic Neurologic Syndrome, migraine,…
UK Electroceuticals Market Size, Share & Forecast 2019-2025
UK has one of the finest healthcare systems in the EU region, which enables it to provide quality healthcare to the individuals. UK has the highest number of cardiovascular diseases, coronary heart disease, stroke, heart failure, atrial fibrillation, and other heart patients. According to British Heart Foundation, more than one-fourth of the fatalities in UK occur due to `, and it is responsible for around 1.6 million fatalities each year.
Request…
North American Electroceuticals Market Growth, Size & Forecast to 2025
The market growth in North America can be attributed to the rising geriatric population, frequent US FDA approvals for innovative electroceutical devices, and growing adoption of minimally invasive/non-invasive surgeries for treatment of several diseases owing to growing awareness among patients related to electroceuticals. The geriatric population is more inclined to the risk of heart strokes. According to WHO, the incidence and prevalence rate of heart attacks are highest in North…